IP Library Granted Patent US 9,238,013
Granted Patent B2
US 9,238,013 · App. 13/746,170 · Granted Jan 19, 2016

Hyaluronic acid-based gels including lidocaine

Inventor: Pierre Lebreton (Annecy, FR)
Assignee: Allergan Industrie, SAS
A61K31/167A61K8/42A61K8/735A61K31/728A61L27/20A61L27/52A61L27/54A61Q19/08A61L2300/402A61L2300/602
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,238,013
App. No.
13/746,170
Granted
Jan 19, 2016
Kind
B2
Abstract

Disclosed herein are cohesive soft tissue fillers, for example, dermal and subdermal fillers, based on hyaluronic acids and pharmaceutically acceptable salts thereof. In one aspect, hyaluronic acid-based compositions described herein include a therapeutically effective amount of at least one anesthetic agent, for example, lidocaine. The present hyaluronic acid-based compositions including lidocaine have an enhanced stability and cohesivity, relative to conventional compositions including lidocaine, for example when subjected to sterilization techniques or when stored for long periods of time. Methods and processes of preparing such hyaluronic acid-based compositions are also provided.

Claims (14)

1. A dermal filler comprising:

(a) a mixture comprising particles of hyaluronic acid crosslinked with 1,4-butanediol diglycidyl ether, and free hyaluronic acid;

(b) about 0.3% by weight lidocaine combined with the mixture;

wherein the dermal filler is heat sterile and has a pH of about 7.

2. The dermal filler of claim 1 wherein the dermal filler requires an extrusion force of between about 10N and about 13N when injected at a rate of about 12.5 mm/minute.

3. The dermal filler of claim 1 wherein the dermal filler has a viscosity of between about 5 Pa*s and about 450 Pa*s when measured at about 5 Hz.

4. A dermal filler comprising:

(a) a hyaluronic acid including particles of crosslinked hyaluronic acid mixed with free hyaluronic acid; and

(b) about 0.3% by weight lidocaine mixed with the hyaluronic acid, wherein:

the crosslinked hyaluronic acid is crosslinked with 1,4-butanediol diglycidyl ether;

the dermal filler being stable at about 25° C. for at least about 6 months after heat sterilization at a temperature of about at least about 120° C. to about 130° C. for a period of at least about 1 minute to about 15 minutes;

the dermal filler having a pH of about 7;

the dermal filler requiring an extrusion force of between about 10N and about 13N when injected at a rate of about 12.5 mm/minute; and

the dermal filler having a viscosity of between about 5 Pa*s and about 450 Pa*s when measured at about 5 Hz.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2014
From: LEBRETON, PIERRE F.
To: ALLERGAN INDUSTRIE, SAS
Reel/Frame 033411/0157 →
Continuity (5)
Continuation 12393884 · Feb 26, 2009
Provisional Application 61085956 · Aug 4, 2008
Provisional Application 61087934 · Aug 11, 2008
Provisional Application 61096278 · Sep 11, 2008
Related Publication 20130131011A1 · May 23, 2013